ALI HEALTH (00241) Reports Interim Results: Adjusted Net Profit Hits RMB1.356 Billion, Up 38.7% YoY

Stock News11-26

ALI HEALTH (00241) announced its interim results for the six months ended September 30, 2025, demonstrating robust and high-quality growth. The group's total revenue reached RMB16.697 billion, reflecting a 17.0% year-on-year increase. Net profit amounted to RMB1.266 billion, surging 64.7% YoY, with the net profit margin expanding from 5.4% to 7.6%. Adjusted net profit stood at RMB1.356 billion, up 38.7% YoY.

As of September 30, 2025, the annualized active consumers on the Tmall Health platform—operated by the company—continued to grow steadily. The platform's gross merchandise volume (GMV) achieved stable, high-quality growth over the past six months, while annualized average revenue per user (ARPU) also increased.

During the reporting period, ALI HEALTH's self-operated business capitalized on supply-side structural optimization in categories like healthcare products, improving operational efficiency. Revenue from this segment rose 18.6% YoY to RMB14.38 billion. The group also deepened collaborations with pharmaceutical companies, expanded partnerships with leading brands, and enhanced user engagement. Both annual active users and member ARPU for the self-operated business showed sustained growth.

Additionally, the group continued investing in AI applications for the healthcare sector. As Alibaba Group's flagship platform in healthcare, ALI HEALTH is advancing AI-driven tools and solutions for B2B medical verticals, addressing growing industry and physician demand. These efforts aim to accelerate breakthroughs in medical AI and drive high-quality business development.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1183277730?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-26 19:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1183277730","market":"us","top_or_hot":-1,"title":"ALI HEALTH (00241) Reports Interim Results: Adjusted Net Profit Hits RMB1.356 Billion, Up 38.7% YoY","media":"Stock News","content":"<p>ALI HEALTH (00241) announced its interim results for the six months ended September 30, 2025, demonstrating robust and high-quality growth. The group's total revenue reached RMB16.697 billion, reflecting a 17.0% year-on-year increase. Net profit amounted to RMB1.266 billion, surging 64.7% YoY, with the net profit margin expanding from 5.4% to 7.6%. Adjusted net profit stood at RMB1.356 billion, up 38.7% YoY.</p>\n<p>As of September 30, 2025, the annualized active consumers on the Tmall Health platform—operated by the company—continued to grow steadily. The platform's gross merchandise volume (GMV) achieved stable, high-quality growth over the past six months, while annualized average revenue per user (ARPU) also increased.</p>\n<p>During the reporting period, ALI HEALTH's self-operated business capitalized on supply-side structural optimization in categories like healthcare products, improving operational efficiency. Revenue from this segment rose 18.6% YoY to RMB14.38 billion. The group also deepened collaborations with pharmaceutical companies, expanded partnerships with leading brands, and enhanced user engagement. Both annual active users and member ARPU for the self-operated business showed sustained growth.</p>\n<p>Additionally, the group continued investing in AI applications for the healthcare sector. As Alibaba Group's flagship platform in healthcare, ALI HEALTH is advancing AI-driven tools and solutions for B2B medical verticals, addressing growing industry and physician demand. These efforts aim to accelerate breakthroughs in medical AI and drive high-quality business development.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ALI HEALTH (00241) Reports Interim Results: Adjusted Net Profit Hits RMB1.356 Billion, Up 38.7% YoY</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nALI HEALTH (00241) Reports Interim Results: Adjusted Net Profit Hits RMB1.356 Billion, Up 38.7% YoY\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-11-26 19:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>ALI HEALTH (00241) announced its interim results for the six months ended September 30, 2025, demonstrating robust and high-quality growth. The group's total revenue reached RMB16.697 billion, reflecting a 17.0% year-on-year increase. Net profit amounted to RMB1.266 billion, surging 64.7% YoY, with the net profit margin expanding from 5.4% to 7.6%. Adjusted net profit stood at RMB1.356 billion, up 38.7% YoY.</p>\n<p>As of September 30, 2025, the annualized active consumers on the Tmall Health platform—operated by the company—continued to grow steadily. The platform's gross merchandise volume (GMV) achieved stable, high-quality growth over the past six months, while annualized average revenue per user (ARPU) also increased.</p>\n<p>During the reporting period, ALI HEALTH's self-operated business capitalized on supply-side structural optimization in categories like healthcare products, improving operational efficiency. Revenue from this segment rose 18.6% YoY to RMB14.38 billion. The group also deepened collaborations with pharmaceutical companies, expanded partnerships with leading brands, and enhanced user engagement. Both annual active users and member ARPU for the self-operated business showed sustained growth.</p>\n<p>Additionally, the group continued investing in AI applications for the healthcare sector. As Alibaba Group's flagship platform in healthcare, ALI HEALTH is advancing AI-driven tools and solutions for B2B medical verticals, addressing growing industry and physician demand. These efforts aim to accelerate breakthroughs in medical AI and drive high-quality business development.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1247","symbol_name":"药品零售","start_time":0,"source_url":"","article_id":"1183277730","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1183277730","pubTimestamp":1764155055,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"ALI HEALTH (00241) announced its interim results for the six months ended September 30, 2025, demonstrating robust and high-quality growth. The group's total revenue reached RMB16.697 billion,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1247":"药品零售","BK1589":"北水核心资产","BK1515":"抗疫概念","BK1142":"互联网与直销零售","BK1591":"就地过年概念","BK1502":"双十一","00241":"阿里健康","BK1615":"港股-互联网","BK1584":"蚂蚁金服概念","BK1189":"医疗保健技术","BK1617":"AI医疗","BK1610":"ETF&股票定投概念","BK1501":"阿里概念股","BK1571":"互联网医疗"},"translate_title":"阿里健康（00241）公布中期业绩：经调整净利润13.56亿元同比增长38.7%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00241":1},"content_text":"ALI HEALTH (00241) announced its interim results for the six months ended September 30, 2025, demonstrating robust and high-quality growth. The group's total revenue reached RMB16.697 billion, reflecting a 17.0% year-on-year increase. Net profit amounted to RMB1.266 billion, surging 64.7% YoY, with the net profit margin expanding from 5.4% to 7.6%. Adjusted net profit stood at RMB1.356 billion, up 38.7% YoY.\nAs of September 30, 2025, the annualized active consumers on the Tmall Health platform—operated by the company—continued to grow steadily. The platform's gross merchandise volume (GMV) achieved stable, high-quality growth over the past six months, while annualized average revenue per user (ARPU) also increased.\nDuring the reporting period, ALI HEALTH's self-operated business capitalized on supply-side structural optimization in categories like healthcare products, improving operational efficiency. Revenue from this segment rose 18.6% YoY to RMB14.38 billion. The group also deepened collaborations with pharmaceutical companies, expanded partnerships with leading brands, and enhanced user engagement. Both annual active users and member ARPU for the self-operated business showed sustained growth.\nAdditionally, the group continued investing in AI applications for the healthcare sector. As Alibaba Group's flagship platform in healthcare, ALI HEALTH is advancing AI-driven tools and solutions for B2B medical verticals, addressing growing industry and physician demand. These efforts aim to accelerate breakthroughs in medical AI and drive high-quality business development.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1183277730","isCrawlerRequest":true}